Lenomorelin

Generic Name
Lenomorelin
Brand Names
-
Drug Type
Biotech
Chemical Formula
-
CAS Number
258279-04-8
Unique Ingredient Identifier
UXG268Q86R
Background

Lenomorelin has been investigated for the treatment and basic science of Cancer, Alcoholism, Metabolism, Hypopituitarism, and Frailty Syndrome, among others.

Associated Conditions
-
Associated Therapies
-

Effects of Ghrelin Administration on Motivation

Not Applicable
Conditions
Interventions
First Posted Date
2024-08-28
Last Posted Date
2024-08-28
Lead Sponsor
University Hospital Tuebingen
Target Recruit Count
40
Registration Number
NCT06576440
Locations
🇩🇪

Department of Psychiatry & Psychotherapy, University of Tübingen, Tübingen, BW, Germany

RCT of Ghrelin in Stroke Patients

Phase 2
Not yet recruiting
Conditions
Interventions
First Posted Date
2023-02-13
Last Posted Date
2023-07-25
Lead Sponsor
Rijnstate Hospital
Target Recruit Count
80
Registration Number
NCT05726240
Locations
🇳🇱

Isala, Zwolle, Netherlands

🇳🇱

Medisch Spectrum Twente, Enschede, Netherlands

🇳🇱

University Medical Center Utrecht, Utrecht, Netherlands

Effects of Ghrelin Administration on Dopamine and Effort

Phase 1
Recruiting
Conditions
Interventions
First Posted Date
2022-04-08
Last Posted Date
2022-04-08
Lead Sponsor
University Hospital Tuebingen
Target Recruit Count
100
Registration Number
NCT05318924
Locations
🇩🇪

Department of Psychiatry & Psychotherapy, University of Tübingen, Tübingen, BW, Germany

Translational and Clinical Aspects of Metabolic, Anabolic and Endothelial Dysfunction in Heart Failure

First Posted Date
2022-03-14
Last Posted Date
2024-10-23
Lead Sponsor
Lars Lund
Target Recruit Count
31
Registration Number
NCT05277415

Unacylated Ghrelin to Improve Functioning in PAD

Phase 2
Recruiting
Conditions
Interventions
First Posted Date
2020-05-06
Last Posted Date
2023-11-07
Lead Sponsor
Northwestern University
Target Recruit Count
30
Registration Number
NCT04377126
Locations
🇺🇸

Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States

🇺🇸

University of Chicago, Chicago, Illinois, United States

Effect of Ghrelin on Decision-Making

Phase 1
Withdrawn
Conditions
Interventions
First Posted Date
2017-06-26
Last Posted Date
2020-01-27
Lead Sponsor
Jenny Tong, MD, MPH
Registration Number
NCT03198143
Locations
🇺🇸

Duke Sociology-Psychology Building 417 Chapel Drive, Durham, North Carolina, United States

Effect of Ghrelin on Glucose Metabolism After Bariatric Surgery

First Posted Date
2016-11-03
Last Posted Date
2023-02-08
Lead Sponsor
Vanderbilt University Medical Center
Target Recruit Count
70
Registration Number
NCT02953587
Locations
🇺🇸

Vanderbilt University Medical Center, Nashville, Tennessee, United States

Preprandial Ghrelin Effect

Phase 1
Completed
Conditions
Interventions
First Posted Date
2016-09-26
Last Posted Date
2019-03-12
Lead Sponsor
Jenny Tong, MD, MPH
Target Recruit Count
80
Registration Number
NCT02913703
Locations
🇺🇸

Duke Center For Living, Durham, North Carolina, United States

Ghrelin Plus Strength Training in Frail Elderly Study

Phase 2
Completed
Conditions
Interventions
First Posted Date
2013-07-12
Last Posted Date
2019-12-11
Lead Sponsor
University of Pennsylvania
Target Recruit Count
16
Registration Number
NCT01898611
Locations
🇺🇸

Clinical and Translational Research Center, University of Pennsylvania, Philadelphia, Pennsylvania, United States

Ghrelin Repeated Dose Study

Phase 2
Completed
Conditions
Interventions
First Posted Date
2013-04-16
Last Posted Date
2015-10-08
Lead Sponsor
University of Pennsylvania
Target Recruit Count
5
Registration Number
NCT01833078
Locations
🇺🇸

University of Pennsylvania, Philadelphia, Pennsylvania, United States

© Copyright 2024. All Rights Reserved by MedPath